NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

WishCare Explores Majority Stake Sale

Kolkata-based WishCare, a prominent skincare and haircare brand, is reportedly exploring a majority stake sale that could value the company at approximately ₹3,000-3,500 crore. This development has been revealed by three individuals with knowledge of the matter.

The proposed sale is a significant step in the company's growth trajectory, as WishCare continues to expand its product portfolio, which includes serums, sunscreens, and hair growth products. While the exact details of the stake sale are still unfolding, the valuation range of ₹3,000-3,500 crore indicates a substantial increase in the company's worth.

As the discussions surrounding the stake sale continue, industry observers will be closely watching the developments to see how they impact the brand's future prospects.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Investor Takeaway

Investors may consider WishCare as a potential opportunity for long-term growth.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.